Episode Details
Back to Episodes
92. The Pfizer–BioNTech playbook for high-stakes partnerships
Description
What happens when you bet billions on a product before knowing if it even works?
In a world where most projects crawl through approval gates, this episode reveals how two unlikely partners Pfizer and BioNTech defied the odds and delivered a game-changing COVID vaccine in under a year.
- Discover how to collapse your project timelines by designing for parallel execution rather than waiting for perfect data
- Learn why involving operations from day one (not the finish line) can de-risk scaling and accelerate delivery
- Understand how building trust equity before the pressure hits enables bold, high-conviction decisions when it counts
Hit play to learn how the Pfizer–BioNTech blueprint can help you fast-track results, strengthen alignment, and lead your next big partnership with confidence.
New episodes Monday, Wednesday and Friday.
More from Phil Hayes-St Clair:
Get 100 proven partnership tactics to earn trust and drive growth through high-value partnerships
This podcast explores business growth through strategic partnerships for sales and marketing leaders, emphasising revenue growth and supply chain management by closing high-value partnerships, identifying the right partners, and building strong relationships based on trust, mutual value, and insights gained from reverse engineering partnerships.
PS - Have a guest recommendation for the show? Share this link with them.